June 20, 2025

Orthofix Medical Inc. (OFIX) Investor Outlook: Assessing the 135.75% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX) is carving a niche in the healthcare sector, particularly in the medical devices industry. With its strategic focus on innovative solutions..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a Potential 244% Upside Despite Challenges

Tilray Brands, Inc. (NASDAQ: TLRY) has emerged as a notable player in the healthcare sector, focusing on specialty and generic drug manufacturing. Despite the challenges inherent..

Oculis Holding AG (OCS) Stock Analysis: Unveiling a 92% Potential Upside in the Biotech Arena

Oculis Holding AG (NASDAQ: OCS), a Swiss biopharmaceutical company, is capturing investor attention with its strong growth potential in the healthcare sector. Specializing in cutting-edge ophthalmic..

KalVista Pharmaceuticals, Inc. (KALV): Investor Outlook Reveals 114.82% Potential Upside in Biotechnology Sector

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and remarkable potential upside. Headquartered in..

Xencor, Inc. (XNCR) Stock Analysis: Unpacking the 237% Potential Upside in Biotech Innovation

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is capturing investor attention with its significant 237% potential upside. Operating within the dynamic biotechnology sector, Xencor is..

Butterfly Network, Inc. (BFLY) Stock Analysis: A 92.90% Upside Potential in the Healthcare Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the healthcare sector specializing in medical devices, has recently captured investor attention with a staggering potential upside..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 60% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a company nestled within the dynamic biotechnology sector, presents an intriguing opportunity for investors with its significant potential upside. With a..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Compelling 85% Upside Potential in the Biotech Sector

Individual investors eyeing opportunities in the biotechnology sector may find Enliven Therapeutics, Inc. (NASDAQ: ELVN) an intriguing prospect. With a market capitalization of $1.27 billion, this..

Owens & Minor, Inc. (OMI) Stock Analysis: Unveiling a 27% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (NYSE: OMI) stands as a notable player in the healthcare sector, specifically within the medical distribution industry. Based in Glen Allen, Virginia,..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech with 257% Potential Upside in the Fight Against IBD

Spyre Therapeutics, Inc. (SYRE) is capturing the attention of investors with its impressive potential upside of 257.43%, a figure that stands out in the volatile world..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating Challenges with Innovative Healthcare Solutions

Semler Scientific, Inc. (NASDAQ: SMLR), a healthcare-focused company based in Santa Clara, California, is making waves in the medical devices industry. With a market capitalization of..

Cronos Group Inc. (CRON) Stock Analysis: Navigating Growth in a Dynamic Cannabis Market

Cronos Group Inc. (NASDAQ: CRON), a cannabinoid company based in Stayner, Canada, is making notable strides in the burgeoning cannabis sector. With a market capitalization of..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges with a 9.74% Potential Upside

Enhabit, Inc. (NASDAQ: EHAB), a notable player in the healthcare sector, specifically within the medical care facilities industry, is carving out its niche in the United..

Neuropace, Inc. (NPCE) Stock Analysis: A Promising 61.56% Upside in the Medical Device Sector

Neuropace, Inc. (NPCE), a key player in the medical devices industry, is making waves with its innovative technologies aimed at treating drug-resistant focal epilepsy. Headquartered in..

Praxis Precision Medicines, Inc. (PRAX) Stock Analysis: Uncovering a Staggering 127% Potential Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a beacon in the biotechnology sector, is capturing investor attention with its significant potential upside of 127.29%. Specializing in innovative..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a 270% Potential Upside in Biotechnology

REGENXBIO Inc. (NASDAQ: RGNX) is capturing the attention of investors with its promising position in the biotechnology sector, especially with a staggering potential upside of 270.48%...

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a Potential 243% Upside

For investors with an eye on the healthcare sector, Vir Biotechnology, Inc. (NASDAQ: VIR) presents a compelling opportunity. Operating within the biotechnology industry, Vir Biotechnology is..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a Compelling 123.76% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology company headquartered in Waltham, Massachusetts, is making waves in the healthcare sector with its focus on precision therapies for..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Navigating a Volatile Biotech Terrain with a 78% Revenue Growth

Sage Therapeutics, Inc. (NASDAQ: SAGE) is making waves in the biotechnology sector with a remarkable 78% revenue growth, drawing the attention of investors focused on companies..

Upstream Bio, Inc. (UPB) Stock Analysis: A Potential 366.79% Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB), a burgeoning name in the biotechnology sector, is generating significant buzz among investors due to its substantial potential upside. With a..

Search

Funds

June 20, 2025

Search

Funds

June 20, 2025

FTSE 100

Funds